AI-generated summary
The authors studied LED photobiomodulation at 630 nm, 850 nm, and both wavelengths combined in an acute radiodermatitis rat model. They report that all LED groups showed a two-point reduction in radiodermatitis severity and higher dermal appendage and vascular counts than controls, with the combined 630 nm plus 850 nm group showing the best results. The study used animals, so applicability to humans is unclear.
- Participants
- 20
- Who or what was studied
- Rats with acute radiodermatitis induced by one radiotherapy session
- Wavelengths
- 630, 850 nm
- Limits stated in the abstract
- The study used an animal model, and the abstract does not describe a sample size per group or statistical details beyond selected P values.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 nm, 850 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Photobiomodulation, Control group, Inflammation, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.